Suggestions
Eben Rosenthal
Medical Director Stanford Cancer Center
Eben Rosenthal, MD, is a prominent figure in the field of otolaryngology and oncology, currently serving as the Chair of the Department of Otolaryngology–Head and Neck Surgery at Vanderbilt University Medical Center. Before his current role, he was the Medical Director of the Stanford Cancer Center from July 2015 to September 2021, where he played a critical role in coordinating cancer care across various departments at Stanford University School of Medicine and Stanford Health Care.124
Education and Early Career
Rosenthal earned his medical degree from the University of Michigan, where he also completed his residency in otolaryngology. He holds board certifications in both otolaryngology and facial plastic and reconstructive surgery. His undergraduate studies were completed at Haverford College.23
Professional Achievements
During his tenure at Stanford, Rosenthal was instrumental in advancing cancer care through initiatives that combined clinical practice with translational research. He led efforts to improve patient experiences and outcomes, focusing on head and neck oncology, microvascular reconstruction, and novel surgical imaging technologies. His research has resulted in over 250 peer-reviewed publications, contributing significantly to advancements in targeted cancer therapies and surgical techniques.125
Prior to joining Stanford, he served as the Chief of the Division for Otolaryngology-Head and Neck Surgery at the University of Alabama at Birmingham (UAB), where he directed an NIH-funded laboratory and developed several first-in-human clinical trials in oncology.24
Current Role
Since October 2021, Rosenthal has been leading the Department of Otolaryngology–Head and Neck Surgery at Vanderbilt University Medical Center. His work continues to focus on enhancing cancer treatment methodologies and improving surgical practices through innovative research.35
In summary, Dr. Eben Rosenthal is a distinguished surgeon-scientist whose leadership in cancer care and commitment to research have made significant impacts on patient treatment protocols and outcomes in the field of oncology.